UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 194

Sortiert nach

An enhanced three-stage design with trend analysis for allergen immunotherapy trials

PloS one, 2023-09, Vol.18 (9), p.e0291533-e0291533

2023

Link zum Volltext

Verfügbarkeit prüfen

EAACI statement on the diagnosis, management and prevention of severe allergic reactions to COVID‐19 vaccines

Allergy (Copenhagen), 2021-06, Vol.76 (6), p.1629-1639

2021

Link zum Volltext

Verfügbarkeit prüfen

Perspectives in allergen immunotherapy: 2019 and beyond

Allergy (Copenhagen), 2019-12, Vol.74 (S108), p.3-25

2019

Link zum Volltext

Verfügbarkeit prüfen

Interferon-α is the primary plasma type-I IFN in HIV-1 infection and correlates with immune activation and disease markers

PloS one, 2013-02, Vol.8 (2), p.e56527

2013

Link zum Volltext

Verfügbarkeit prüfen

IRF1 Maintains Optimal Constitutive Expression of Antiviral Genes and Regulates the Early Antiviral Response

Frontiers in immunology, 2019-05, Vol.10, p.1019-1019

2019

Link zum Volltext

Verfügbarkeit prüfen

A three‐stage design for allergen immunotherapy trials

Allergy (Copenhagen), 2022-06, Vol.77 (6), p.1835-1842

2022

Link zum Volltext

Verfügbarkeit prüfen

Oral Immunotherapy for Food Allergy—a US Regulatory Perspective

Current allergy and asthma reports, 2020-12, Vol.20 (12), p.77-77, Article 77

2020

Link zum Volltext

Verfügbarkeit prüfen

The History, Present and Future of Allergen Standardization in the United States and Europe

Frontiers in immunology, 2021-09, Vol.12, p.725831-725831

2021

Link zum Volltext

Verfügbarkeit prüfen

Shared and Unique Features of Human Interferon-Beta and Interferon-Alpha Subtypes

Frontiers in immunology, 2021-01, Vol.11, p.605673-605673

2021

Link zum Volltext

Verfügbarkeit prüfen

Respiratory syncytial virus interferon antagonist NS1 protein suppresses and skews the human T lymphocyte response

PLoS pathogens, 2011-04, Vol.7 (4), p.e1001336-e1001336

2011

Link zum Volltext

Verfügbarkeit prüfen

Regulation of allergen immunotherapy products in Europe and the United States

Journal of allergy and clinical immunology, 2019-10, Vol.144 (4), p.1140-1140

2019

Link zum Volltext

Verfügbarkeit prüfen

Editorial: Structures, Signaling Mechanisms, and Functions of Types I and III Interferons

Frontiers in immunology, 2021-02, Vol.12, p.638479-638479

2021

Link zum Volltext

Verfügbarkeit prüfen

A regulator’s view on AIT clinical trials in the United States and Europe: Why successful studies fail to support licensure

Journal of allergy and clinical immunology, 2022-03, Vol.149 (3), p.812-818

2022

Link zum Volltext

Verfügbarkeit prüfen

Strand-Specific Dual RNA Sequencing of Bronchial Epithelial Cells Infected with Influenza A/H3N2 Viruses Reveals Splicing of Gene Segment 6 and Novel Host-Virus Interactions

Journal of virology, 2018-09, Vol.92 (17)

2018

Link zum Volltext

Verfügbarkeit prüfen

Type I and Type III Interferons Display Different Dependency on Mitogen-Activated Protein Kinases to Mount an Antiviral State in the Human Gut

Frontiers in immunology, 2017-04, Vol.8, p.459-459

2017

Link zum Volltext

Verfügbarkeit prüfen

Mycobacterium tuberculosis triggers host type I IFN signaling to regulate IL-1β production in human macrophages

The Journal of immunology (1950), 2011-09, Vol.187 (5), p.2540-2547

2011

Link zum Volltext

Verfügbarkeit prüfen

Differential Responses by Human Respiratory Epithelial Cell Lines to Respiratory Syncytial Virus Reflect Distinct Patterns of Infection Control

Journal of virology, 2018-08, Vol.92 (15)

2018

Link zum Volltext

Verfügbarkeit prüfen

Suppression of the Induction of Alpha, Beta, and Gamma Interferons by the NS1 and NS2 Proteins of Human Respiratory Syncytial Virus in Human Epithelial Cells and Macrophages

Journal of Virology, 2004-04, Vol.78 (8), p.4363-4369

2004

Link zum Volltext

Verfügbarkeit prüfen

Expression profiles of human interferon‐alpha and interferon‐lambda subtypes are ligand‐ and cell‐dependent

Immunology and cell biology, 2012-09, Vol.90 (8), p.774-783

2012

Link zum Volltext

Verfügbarkeit prüfen

Allergenic extracts to diagnose and treat sensitivity to insect venoms and inhaled allergens

Annals of allergy, asthma, & immunology, 2017-05, Vol.118 (5), p.531-536

2017

Link zum Volltext

Verfügbarkeit prüfen

Developmental regulation of type 1 and type 3 interferon production and risk for infant infections and asthma development

Journal of allergy and clinical immunology, 2019-03, Vol.143 (3), p.1176-1182.e5

2019

Link zum Volltext

Verfügbarkeit prüfen

Diversity and complexity of mouse allergens in urine, house dust, and allergen extracts assessed with an immuno‐allergomic approach

Allergy (Copenhagen), 2021-12, Vol.76 (12), p.3723-3732

2021

Link zum Volltext

Verfügbarkeit prüfen

Multiplex assay for high throughput potency and stability measurement of all known German cockroach (GCr) allergens: A step toward full characterization

Journal of allergy and clinical immunology, 2018-02, Vol.141 (2), p.AB286-AB286

2018

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 194

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(175)
Mit Volltextzugriff
(168)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(194)
Japanisch
(17)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

An enhanced three-stage design with trend analysis for allergen immunotherapy trials

EAACI statement on the diagnosis, management and prevention of severe allergic reactions to COVID‐19 vaccines

Perspectives in allergen immunotherapy: 2019 and beyond

Interferon-α is the primary plasma type-I IFN in HIV-1 infection and correlates with immune activation and disease markers

IRF1 Maintains Optimal Constitutive Expression of Antiviral Genes and Regulates the Early Antiviral Response

A three‐stage design for allergen immunotherapy trials

Oral Immunotherapy for Food Allergy—a US Regulatory Perspective

The History, Present and Future of Allergen Standardization in the United States and Europe

Shared and Unique Features of Human Interferon-Beta and Interferon-Alpha Subtypes

Technical standards in allergen exposure chambers worldwide – an EAACI Task Force Report

Respiratory syncytial virus interferon antagonist NS1 protein suppresses and skews the human T lymphocyte response

Regulation of allergen immunotherapy products in Europe and the United States

Editorial: Structures, Signaling Mechanisms, and Functions of Types I and III Interferons

A regulator’s view on AIT clinical trials in the United States and Europe: Why successful studies fail to support licensure

Strand-Specific Dual RNA Sequencing of Bronchial Epithelial Cells Infected with Influenza A/H3N2 Viruses Reveals Splicing of Gene Segment 6 and Novel Host-Virus Interactions

Type I and Type III Interferons Display Different Dependency on Mitogen-Activated Protein Kinases to Mount an Antiviral State in the Human Gut

Mycobacterium tuberculosis triggers host type I IFN signaling to regulate IL-1β production in human macrophages

Differential Responses by Human Respiratory Epithelial Cell Lines to Respiratory Syncytial Virus Reflect Distinct Patterns of Infection Control

Suppression of the Induction of Alpha, Beta, and Gamma Interferons by the NS1 and NS2 Proteins of Human Respiratory Syncytial Virus in Human Epithelial Cells and Macrophages

Expression profiles of human interferon‐alpha and interferon‐lambda subtypes are ligand‐ and cell‐dependent

Allergenic extracts to diagnose and treat sensitivity to insect venoms and inhaled allergens

Developmental regulation of type 1 and type 3 interferon production and risk for infant infections and asthma development

Diversity and complexity of mouse allergens in urine, house dust, and allergen extracts assessed with an immuno‐allergomic approach

Multiplex assay for high throughput potency and stability measurement of all known German cockroach (GCr) allergens: A step toward full characterization

Evaluation of association of anti-PEG antibodies with anaphylaxis after mRNA COVID-19 vaccination

Suchergebnisse filtern